- Home
- VYGR vs ALTG Comparison
VYGR vs ALTG Comparison
Compare VYGR & ALTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- ALTG
- Stock Information
- Founded
- VYGR 2013
- ALTG 1984
- Country
- VYGR United States
- ALTG United States
- Employees
- VYGR N/A
- ALTG N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- ALTG Industrial Machinery/Components
- Sector
- VYGR Health Care
- ALTG Industrials
- Exchange
- VYGR Nasdaq
- ALTG Nasdaq
- Market Cap
- VYGR 231.9M
- ALTG 247.6M
- IPO Year
- VYGR 2015
- ALTG N/A
- Fundamental
- Price
- VYGR $4.21
- ALTG $7.63
- Analyst Decision
- VYGR Strong Buy
- ALTG Hold
- Analyst Count
- VYGR 8
- ALTG 3
- Target Price
- VYGR $16.71
- ALTG $11.67
- AVG Volume (30 Days)
- VYGR 635.7K
- ALTG 264.2K
- Earning Date
- VYGR 11-11-2025
- ALTG 11-11-2025
- Dividend Yield
- VYGR N/A
- ALTG 3.00%
- EPS Growth
- VYGR N/A
- ALTG N/A
- EPS
- VYGR N/A
- ALTG N/A
- Revenue
- VYGR $42,580,000.00
- ALTG $1,851,100,000.00
- Revenue This Year
- VYGR N/A
- ALTG $1.30
- Revenue Next Year
- VYGR $107.07
- ALTG $3.26
- P/E Ratio
- VYGR N/A
- ALTG N/A
- Revenue Growth
- VYGR N/A
- ALTG N/A
- 52 Week Low
- VYGR $2.65
- ALTG $3.54
- 52 Week High
- VYGR $8.28
- ALTG $8.99
- Technical
- Relative Strength Index (RSI)
- VYGR 62.64
- ALTG 45.29
- Support Level
- VYGR $3.91
- ALTG $7.27
- Resistance Level
- VYGR $4.51
- ALTG $8.68
- Average True Range (ATR)
- VYGR 0.27
- ALTG 0.33
- MACD
- VYGR 0.05
- ALTG -0.11
- Stochastic Oscillator
- VYGR 74.79
- ALTG 22.36
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.